999 Piyanping

999 Piyanping is a Chinese topical dermatology brand associated with China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. The name is commonly used for cream products marketed for the relief of inflammatory and itchy skin conditions. Its best-known products are topical formulations containing dexamethasone acetate, a corticosteroid ingredient, although the exact active ingredients and indications differ by product variant and should be verified from the package labeling and official regulatory information. The brand belongs to the broader 999 consumer-health portfolio, one of the most recognizable over-the-counter pharmaceutical identities in China. In the domestic market, Piyanping has traditionally been positioned as an accessible household skin-treatment product sold through pharmacies and other retail channels. Its consumer recognition is linked to the strong “999” master brand, which is also used across other healthcare categories. The product name itself combines the brand identity with “皮炎平,” a Chinese term associated with dermatitis-relief cream, making the therapeutic purpose immediately legible to Chinese consumers. Piyanping is not a general-purpose cosmetic skincare line. It is a medicinal topical product family, and its use is governed by the approved indications, dosage instructions, contraindications, and warnings for each formulation. Corticosteroid creams can be clinically useful for appropriate inflammatory skin conditions but may be unsuitable for some infections, facial conditions, children, prolonged unsupervised use, or other situations. Accordingly, responsible positioning emphasizes label compliance and consultation with healthcare professionals when symptoms persist or the diagnosis is uncertain. The brand’s commercial importance comes primarily from domestic consumer familiarity rather than from a separately disclosed global operating footprint. Publicly available brand-level information does not establish a distinct international corporate structure, standalone financial reporting, or an independently documented founding event for 999 Piyanping. It is therefore best understood as a product brand within the China Resources Sanjiu healthcare portfolio rather than as an independent company.

999 Piyanping developed as part of the 999 healthcare brand system associated with China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. The product name became familiar in China through topical cream products intended for dermatitis-related symptoms and other approved inflammatory or itchy skin conditions. Unlike an independent pharmaceutical company, the brand does not have a separately documented corporate history in the available reference material; its development is therefore best described through the history of the 999 consumer-health portfolio and its parent company. The brand’s identity is built around two elements. “999” connects the product with a broad, nationally recognized Chinese pharmaceutical and healthcare trademark, while “皮炎平” communicates a dermatitis-relief use case in plain consumer language. This combination helped the product function as a recognizable pharmacy item rather than as a specialist prescription-only identity. Its red and green package variants are widely associated with different formulations or positioning within the product family, but product composition and approved uses must be checked individually because packaging color alone is not a substitute for the official label. The core therapeutic proposition is topical relief for specified inflammatory and itchy skin conditions. Some Piyanping products contain dexamethasone acetate or another corticosteroid formulation. Such medicines have a defined role in treating inflammation but require appropriate diagnosis and duration of use. They are not interchangeable with moisturizers or cosmetic creams, and inappropriate or prolonged use can create safety concerns. This distinction has shaped the brand’s place in the Chinese market: it is a familiar consumer-health product, but its use remains subject to pharmaceutical labeling, regulatory requirements, and professional advice. Distribution has principally been associated with China’s pharmacy and retail healthcare channels, supported by the visibility of the 999 master brand. The available material does not support a reliable standalone founding year, founder attribution, original launch date, international market list, or independent financial history for Piyanping. No separate public listing exists for the product brand; any listed-company status derives from its parent company. On the evidence available, 999 Piyanping remains an active domestic product family within China Resources Sanjiu’s broader pharmaceutical and consumer-health business.

• Integration into the 999 healthcare portfolio

  999 Piyanping became established as a topical dermatology product family under the broader 999 pharmaceutical brand. A precise launch year is not confirmed in the available material.

• Expansion of topical product variants

  The brand came to be represented by multiple package and formulation variants, including commonly recognized red and green versions. Exact variant launch dates are not confirmed.

An accessible Chinese pharmacy-oriented topical dermatology brand under the 999 consumer-health portfolio, centered on relief of itching and inflammation associated with approved skin conditions.

• Topical dermatology medicine

  999 Piyanping cream

  The core product family consists of topical creams marketed for relief of symptoms associated with approved inflammatory and itchy skin conditions. Product composition varies by version; commonly referenced formulations include dexamethasone acetate. The product should be used only according to the package labeling and applicable medical advice, particularly for children, facial use, suspected infections, prolonged treatment, or recurrent symptoms.

• Topical corticosteroid medicine

  Red-packaged 999 Piyanping

  A widely recognized presentation within the Piyanping family. It is associated with a topical corticosteroid cream formulation and is intended for specified dermatological indications rather than unrestricted cosmetic use. The exact active ingredient, strength, indications, and warnings should be confirmed from the current registered package insert.

• Topical skin-treatment medicine

  Green-packaged 999 Piyanping

  A separate presentation recognized within the brand family. Package color is used commercially to distinguish variants, but it does not by itself establish therapeutic equivalence with other Piyanping products. Consumers should rely on the formulation name, active ingredients, approved indications, and warnings shown on the specific product label.

• 2019

  Source 1Source 2

Read more

1. 1《吐槽大会》违法植入皮炎平广告被罚90万元ce.cn
2. 2《吐槽大会》违法植入皮炎平广告被罚90万元finance.sina.com.cn